GridAI Technologies GRDX
NASDAQ GRDX
$3.02 +0.00 (+0.00%)
As of: Sep 10, 2026 · 2:30 PM EDT

GridAI Technologies (GRDX) EBIT (2015 - 2026)

GridAI Technologies' (GRDX) quarterly EBIT came in at -$13.1 million in Q2 2026, down 1951.57% on a YoY basis from $707871.7 in Q2 2025, and down 179.56% quarter-over-quarter from -$4.7 million in Q4 2025.

Analysis

GridAI Technologies (GRDX) EBIT (2015 - 2026) Analysis & Trends

GridAI Technologies (GRDX) has reported EBIT for 12 consecutive years, with -$13.1 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, EBIT fell 1951.57% year-over-year to -$13.1 million; the trailing twelve-month figure through Jun 2026 stood at -$19.4 million (down 325.09% YoY), and the FY2025 full-year result was -$7.1 million, up 54.66% from the prior year.
  • EBIT retreated to -$13.1 million in Q2 2026 per GRDX's latest filing, from -$4.7 million in the prior quarter.
  • Across five years, EBIT topped out at $4.4 million in Q3 2022 and bottomed at -$13.1 million in Q2 2026.
  • Historically, EBIT has averaged -$3.8 million across 5 years, with a median of -$3.4 million in 2023.
  • The sharpest annual moves came in 2022 and 2026: EBIT jumped 114.44% in 2022, then plunged 1951.57% in 2026.
  • Over 5 years, EBIT stood at -$2.3 million in 2022, then tumbled by 79.57% to -$4.1 million in 2023, then jumped by 70.6% to -$1.2 million in 2024, then tumbled by 289.56% to -$4.7 million in 2025, then plunged by 179.56% to -$13.1 million in 2026.
  • According to Business Quant data, EBIT over the past three periods registered -$13.1 million, -$4.7 million, and -$934787.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Amgen 206.12 Bn 192.13 Bn 7.24 Bn 3.51 Bn
2 Gilead Sciences 180.16 Bn 176.98 Bn 6.22 Bn -10.39 Bn
3 Vertex Pharmaceuticals 131.52 Bn 123.67 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 81.95 Bn 73.96 Bn 3.93 Bn 1.29 Bn
5 Argenx Se 60.36 Bn 55.18 Bn 1.37 Bn 493.00 Mn
6 Moderna 53.81 Bn 48.67 Bn 52.00 Mn -815.00 Mn
7 Alnylam Pharmaceuticals 33.01 Bn 29.70 Bn 992.69 Mn 231.44 Mn
8 Biogen 31.96 Bn 30.67 Bn 1.96 Bn -644.50 Mn
9 Roivant Sciences 29.25 Bn 29.25 Bn 1.16 Mn -365.99 Mn
10 GridAI Technologies 19.39 Mn 19.39 Mn -36,514.00 -13.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -13.11 Mn
Dec 31, 2025 -4.69 Mn
Sep 30, 2025 -934,787.00
Jun 30, 2025 -638,864.00
Mar 31, 2025 -821,386.00
Dec 31, 2024 -1.20 Mn
Sep 30, 2024 -1.89 Mn
Jun 30, 2024 -3.43 Mn
Mar 31, 2024 -9.10 Mn
Dec 31, 2023 -4.09 Mn
Sep 30, 2023 -3.43 Mn
Jun 30, 2023 -4.18 Mn
Mar 31, 2023 -4.06 Mn
Dec 31, 2022 -2.28 Mn
Sep 30, 2022 4.39 Mn
Jun 30, 2022 -5.41 Mn
Mar 31, 2022 -9.38 Mn
Dec 31, 2021 -11.17 Mn
Sep 30, 2021 -30.40 Mn
Jun 30, 2021 -9.28 Mn